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Background/aim: Repaglinide (RG) is a prandial glucose regulator used for the treatment of type 2 diabetes. Our recent study showed
that RG plays an important role in cyclosporine A (CsA)-induced nephrotoxicity through its antioxidant properties. However, it is
not known whether or not RG has any protective effect on CsA-induced renal tubular toxicity by affecting apoptosis and expression of
apoptosis-associated protein. The purpose of this study was to investigate the effects of RG on CsA-induced renal tubule apoptosis and
Bax and Bcl-2 protein expression in rats.
Materials and methods: Forty male Sprague Dawley rats weighing 250–300 g were randomly divided into four groups: administrations
of olive oil (control, per os (PO)), CsA (30 mg/kg in olive oil, subcutaneous (SC)), and RG (0.2 or 0.4 mg/kg, PO) plus CsA (30 mg/kg
in olive oil, SC) every day for 15 days.
Results: Our results showed that SC administration of CsA (30 mg/kg) to rats produced marked injury and apoptosis, elevation of Bax
protein expression, and inhibition of Bcl-2 protein expression in the kidneys, which were reversed significantly by oral administration
of RG (0.2 or 0.4 mg/kg).
Conclusion: The findings of our study indicate that RG may play an important role in protecting the kidneys through inhibiting
apoptosis, Bax, and Bcl-2 protein expression.
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1. Introduction
Repaglinide (RG) is an oral antihyperglycemic agent
used for the treatment of noninsulin-dependent diabetes
mellitus. It belongs to the meglitinide class of short-acting
insulin secretagogues, which act by binding to β cells of
the pancreas to stimulate insulin release (1). It has been
reported that RG treatment decreases the concentration
of lipid hydroperoxide (LPO) and increases the activity
of superoxide dismutase (SOD) in kidneys of diabetic
nephropathy (2–6). Cyclosporine A (CsA) is a drug
used to treat many autoimmune diseases and to prevent
transplant rejection. Nephrotoxicity constitutes its main
adverse effect and can cause acute or chronic kidney
damage (7). Many studies demonstrated that CsA-induced
nephrotoxicity is mediated by oxidative damage (8–10).
Our recent study showed that RG plays an important role
in CsA-induced nephrotoxicity through its antioxidant
properties (11).

Other studies showed that CsA-induced cytotoxicity
was related to apoptosis in renal tubular or endothelial
cells (12,13). It is not known, however, whether RG has any
effect on CsA-induced renal tubular apoptosis by affecting
the expression of apoptosis-associated proteins. Therefore,
the purpose of the present study was to investigate the
effects of RG on CsA-induced renal tubular apoptosis, and
the expression of Bax and Bcl-2 proteins in rats.
2. Materials and methods
2.1. Animals and treatment
Adult male Sprague Dawley rats weighing 250–300 g were
used. The animals were obtained from the Experimental
Research Centre, Wuhan, China. The animals were
maintained at 25 °C in a room with a 12/12 light/dark
cycle and had free access to water and food.
Forty rats were randomly allocated into 4 groups (n =
10). Olive oil (1 mL) was administered by gavage (IG) to
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the first (normal control) group every day for 15 days, and
in the second (CsA model control) group, the rats were
given subcutaneous (SC) CsA (Novartis Pharma GmbH,
Mannheim, Germany) injection, 30 mg/kg in olive oil daily
for 15 days. The CsA rats of the third and the fourth groups
received RG (Sigma, St. Louis, MO, USA) (IG) at doses of
0.2 mg/kg and 0.4 mg/kg daily for 15 days, respectively.
To prevent a RG-induced rat hypoglycemia reaction, 5%
glucose administration by IG after per os RG was given
daily during the experimental period.
At the end of day 15, animals in all groups were
anesthetized with 45 mg/kg sodium pentobarbital and
sacrificed by decapitation.

2.5. Statistical analysis
Apoptosis was expressed as mean ± standard deviations
(n = 10). The results were analyzed by Student’s t-test
and one-way analysis of variance (ANOVA). The effect
was considered significant when the P value was < 0.05.
All statistical analyses were performed using SPSS 17.0
(Released Aug. 23, 2008), Chicago, IL, USA.

2.3. Apoptosis assay
Apoptosis in kidney cells was analyzed using a method
that was described previously (14). The TUNEL assay
was done by the in situ cell death detection kit (Beijing
Zhongshan Biotechnology Co. Ltd, Beijing, China)
according to the manufacturer’s instruction. Paraffin waxembedded tissue sections were treated with proteinase K
(Sigma), and endogenous peroxidase activity was blocked
by incubating with hydrogen peroxide. The sections
were incubated at 37 °C for 60 min followed by rinsing
the slides with phosphate-buffered saline (PBS). Nuclear
labeling was developed with horseradish peroxidase and
diaminobenzidine. Counterstaining was achieved by
hematoxylin. When viewed under a light microscope,
apoptotic nuclei were stained brown and nonapoptotic
nuclei were blue. Apoptosis rate % = number of apoptotic
cells/total cells × 100%.

3. Results
3.1. Histological results
The kidneys of the control group rats showed normal
histological structure of glomerular and tubular structures
(Figure 1A). Kidney tissues in the CsA treatment model
group had significant morphological alterations compared
to those of the control group, including tubular swelling and
protein casts (Figure 1B). The kidneys of the RG-treated
(0.2 mg/kg) rats showed focal tubular swelling and protein
casts (Figure 1C), while the kidneys of those medicated
with RG (0.4 mg/kg) showed no obvious histopathological
change, and the harm to the kidneys was reversed in the
RG-treated (0.4 mg/kg) groups (Figure 1D).
3.2. Immunohistochemical analysis
Immunohistochemical analysis demonstrated that the
control rats had little kidney tubular cell apoptosis (Table;
Figure 2A). In contrast, significant apoptosis was observed
in the group treated with CsA (Table; Figure 2B). RG (0.2
mg/kg) decreased kidney tubular cell apoptosis in the
CsA-treated rats (P < 0.05) (Table; Figure 2C). When the
dose of RG was increased to 0.4 mg/kg, its inhibitory effect
on CsA-induced apoptosis was more pronounced (P <
0.01) (Table; Figure 2D).
The expression of Bax protein in renal tubular cells
in the CsA group was higher compared with that in
the control group (Figure 3B), while Bcl-2 protein was
obviously lower than in the CsA group (Figure 4B). The
RG-treated (0.2 mg/kg) group had slight effect on the
changes in the protein expression of Bax and Bcl-2 induced
by CsA (Figures 3C and 4C) while that of RG at a higher
dose (0.4 mg/kg) had a more dramatic effect (Figures 3D
and 4C).

2.4. Bcl-2 and Bax assay
Immunohistochemical assay of Bcl-2 and Bax assay were
performed as described previously (15,16). Briefly, kidney
tissues were fixed in 4% formaldehyde for 24 h followed by
embedding in paraffin, and then cut into 4-μm slices using
a microtome. The streptavidin peroxidase (SP) method
was employed. The Bcl-2 monoclonal antibody (Beijing,
China) (1:50) or Bax polyclonal antibody (Beijing, China)
(1:50) was incubated with the slices overnight at 4 °C or
for 60 min at room temperature. The slices were observed
and photographed under a light microscope and positive
cytoplasm cells were stained yellow-brown.

4. Discussion
Apoptosis, or programmed cell death, has an essential role
in development but also is the basis of many tissue lesions.
It is regulated by a wide variety of factors, especially those
belonging to the Bcl-2 family: inhibitors (i.e. Bcl-2 protein)
and promoters (i.e. Bax protein) (17). Apoptosis regulator
Bax, also known as Bcl-2-like protein 4, is a protein that
is encoded by the Bax gene in humans. Bax is a member
of the Bcl-2 gene family. Bcl-2 family members form
hetero- or homodimers and act as anti- or proapoptotic
regulators that are involved in a wide variety of cellular
activities. This protein forms a heterodimer with Bcl-2

2.2. Histopathological examination
The animals were euthanized; their kidneys were collected
and kept in 10% neutral buffered formalin for 48 h and
then embedded within paraffin. Sections of 4 µm thickness
were prepared using a rotary microtome. The sections
were stained with hematoxylin and eosin (H and E).
The morphological characteristics were assessed by light
microscopy.
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Figure 1. Light microscopy of kidney tissues from rats (HE stained kidney sections,
400×) (A) The control group: normal renal tubules. (B) The CsA group: tubules show
extensive and marked swelling and protein casts (arrows). (C) The RG (0.2 mg/kg)
+ CsA group: tubules show swelling and obvious decrease in protein casts (arrows).
(D) The RG (0.4 mg/kg) + CsA group: tubules show only a few and slight protein
casts (arrows).
Table. Effect of repaglinide on cyclosporine A-induced renal
tubule apoptosis. Data are expressed as mean ± SEM.
Group

Apoptosis rate/%

Control

0.32 ± 0.14

CsA (30 mg/kg)

7.62 ± 4.20 **

RG (0.2 mg/kg) + CsA

5.24 ± 0.87#

RG (0.4 mg/kg) + CsA

0.68 ± 0.26 ##

Data given are the mean ± standard deviations (n = 10).
**
Significantly different from the control group (P < 0.01).
#
Significantly different from cyclosporine A group (P < 0.05).
##
Significantly different from cyclosporine A group (P < 0.01).

and functions as an apoptotic activator. This protein is
reported to interact with, and increase the opening of the
mitochondrial voltage-dependent anion channel (VDAC),
which leads to loss in membrane potential and release of
cytochrome c (18). Previous studies showed that increased
Bcl-2 expression overall correlated with better survival
rates, while overexpression of Bax played a role in the
assessment of sensitivity for therapy (19,20).
Apoptosis plays an important role in the normal
function and development of the kidneys. The apoptotic
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process within the kidney during organ development and
during regeneration of tubules following renal damage
helps appropriate nephron development and tubular repair
after damage (21). Previous reports showed that renal
diseases that have a dysregulated apoptotic process often
cause loss of kidney function, abnormal development, or
accelerated growth. The mitochondria pathway combines
stress and developmental apoptotic factors, and this
process is triggered by translocation of a proapoptotic Bcl2 family member such as Bax into mitochondria (21,22).
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Figure 2. Effect of repaglinide on CsA-induced kidney tubular cell apoptosis (TUNEL,
400×). Apoptotic nuclei stained brown, nonapoptotic nuclei stained blue. (A) The
control group: no kidney tubular cell apoptosis. (B) The CsA group: obvious kidney
tubular cell apoptosis. (C) The RG (0.2 mg/kg) + CsA group: less kidney tubular cell
apoptosis. (D) The RG (0.4 mg/kg) + CsA group: little kidney tubular cell apoptosis.

Figure 3. Effect of repaglinide on CsA-induced changes in the expression of kidney
tubular cell Bax protein (SP, 400×). Cytoplasm was stained brown-yellow in Bax
protein expression. (A) The control group: Bax was minimally expressed. (B) The
CsA group: Bax expression was abundant. (C) The RG (0.2 mg/kg) + CsA group:
Bax expression was weak. (D) The RG (0.4 mg/kg) + CsA group: Bax expression was
very weak.
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Figure 4. Effect of repaglinide on CsA-induced changes in the expression of kidney
tubular cell Bcl-2 protein (SP, 400×). Cytoplasm was stained brown-yellow in Bcl2 protein expression. (A) The control group: bcl-2 expression was abundant. (B)
The CsA group: little bcl-2 expression. (C) The RG (0.2 mg/kg) + CsA group: bcl-2
expression was weak. (D) The RG (0.4 mg/kg) + CsA group: expression of bcl-2 was
very abundant.

For example, CsA-induced cytotoxicity was related to
apoptosis in tubular or endothelial cells (12,13). However,
the apoptotic pathway can potentially be modulated to
maintain cell viability. Moreover, the components of the
apoptotic pathway are amenable to therapeutic modulation
(23).
In the current study, we present results of an
immunohistochemical analysis of renal tubular cell
apoptosis and apoptosis-associated protein expression in
CsA-induced renal tubular injury. Our study showed that
CsA induced significant apoptosis in renal tubular cells.
Moreover, CsA significantly increased the expression of
Bax protein and decreased the expression of Bcl-2 protein.
Our findings are in accordance with previous reports
where CsA induces kidney tubular cell apoptosis (12,13).
RG significantly inhibited renal tubular cell apoptosis and
increased the expression of Bcl-2 protein and reduced
the expression of Bax protein in CsA-induced renal
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tubular toxicity. Therefore, RG effectively reverses CsAinduced renal tubular toxicity and this may be related to
the inhibition of renal tubular cell apoptosis. The present
study provides evidence that RG may have certain degrees
of renoprotection by affecting apoptosis and expression of
apoptosis-associated proteins. The mechanisms by which
RG affects apoptosis need further study.
In conclusion, the results of our study indicate that
CsA causes renal tubular toxicity by inducing apoptosis.
RG may play a renoprotective role in CsA-induced renal
tubular toxicity by suppressing apoptosis.
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